Company / Working Capital per Share
Cartesian Therapeutics, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$4.44
FY2025
5-year range
$0.15 / $35.88
FY2021-FY2025
Trend
-87.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has fluctuated over the past 8 years, ranging from $0.15 in FY2023 to $35.88 in FY2024.
Based on SEC 10-K filings.
4.44 in FY2025 with a 5-year CAGR of +40.6%.
Improved from $0.15 to $4.44 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +64.6%
- 5-Year CAGR
- +40.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital per share decreased 87.6% year-over-year.
- Peak working capital per share was recorded in FY2024.
- Lowest working capital per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.44 | -87.6% |
| FY2024 | $35.88 | +24281.5% |
| FY2023 | $0.15 | -85.2% |
| FY2022 | $1.00 | +49.0% |
| FY2021 | $0.67 | -17.4% |
| FY2020 | $0.81 | -70.6% |
| FY2019 | $2.75 | -91.8% |
| FY2016 | $33.64 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026